ORASURE TECHNOLOGIES, INC Proceeds from Maturities, Prepayments and Calls of Short-term Investments
ORASURE TECHNOLOGIES, INC (OSUR) reported Proceeds from Maturities, Prepayments and Calls of Short-term Investments of $18.59 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments · last filed 2017-08-09
- ORASURE TECHNOLOGIES, INC proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2016-12-31 was $7.46M, a 0.39% decline year-over-year.
- ORASURE TECHNOLOGIES, INC proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2016-09-30 was $7.63M, a 2.42% increase year-over-year.
- ORASURE TECHNOLOGIES, INC proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2016-06-30 was $7.65M, a 91.20% increase year-over-year.
- ORASURE TECHNOLOGIES, INC proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2016-03-31 was $7.69M, a 53.78% increase year-over-year.
- ORASURE TECHNOLOGIES, INC proceeds from maturities, prepayments and calls of short-term investments for fiscal 2016 was $30.42M, a 27.10% increase from fiscal 2015.
- ORASURE TECHNOLOGIES, INC proceeds from maturities, prepayments and calls of short-term investments for fiscal 2015 was $23.93M, a 440.03% increase from fiscal 2014.
- ORASURE TECHNOLOGIES, INC proceeds from maturities, prepayments and calls of short-term investments for fiscal 2014 was $4.43M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 3 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 6 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 9 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 12 month |
|---|---|---|---|---|
| 2017-06-30 | $18.59M 10-Q · filed 2017-08-09 | |||
| 2016-12-31 | $7.46M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $15.09M derived: sum of 2 quarters · filed 2017-03-14 | $22.73M derived: sum of 3 quarters · filed 2017-08-09 | $30.42M 10-K · filed 2017-03-14 |
| 2016-09-30 | $7.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $15.28M derived: sum of 2 quarters · filed 2017-08-09 | $22.97M 10-Q · filed 2016-11-08 | $30.45M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-06-30 | $7.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $15.34M 10-Q · filed 2017-08-09 | $22.82M derived: sum of 3 quarters · filed 2017-08-09 | $30.27M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | $7.69M 10-Q · filed 2017-05-09 | $15.17M derived: sum of 2 quarters · filed 2017-05-09 | $22.62M derived: sum of 3 quarters · filed 2017-05-09 | $26.62M derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | $7.48M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $14.94M derived: sum of 2 quarters · filed 2017-03-14 | $18.93M derived: sum of 3 quarters · filed 2017-03-14 | $23.93M 10-K · filed 2017-03-14 |
| 2015-09-30 | $7.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $11.45M derived: sum of 2 quarters · filed 2016-11-08 | $16.45M 10-Q · filed 2016-11-08 | $16.45M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $9.00M 10-Q · filed 2016-08-08 | $9.00M derived: sum of 3 quarters · filed 2017-03-14 | |
| 2015-03-31 | $5.00M 10-Q · filed 2016-05-10 | $5.00M derived: sum of 2 quarters · filed 2017-03-14 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $4.43M 10-K · filed 2017-03-14 | ||
| 2014-09-30 | $4.43M 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |